Transdiagnostic Sleep and Circadian Treatment for Autistic Adolescents

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-17
SponsorMilton S. Hershey Medical Center

About this trial

Sleep and circadian problems are associated with deleterious social, emotional, and cognitive outcomes, yet are modifiable. This prospective study will adapt and optimize an empirically supported behavioral intervention that addresses common sleep and circadian problems of autistic adolescents, who are at increased risk for mental health disorders, using a transdiagnostic approach. The knowledge gained from this study will help to address a critical need for accessible transdiagnostic sleep interventions for autistic adolescents, who experience a broad range of sleep and circadian problems at high rates and often lack access to specialty care treatment.

Eligibility criteria

Qualifiers

Autistic adolescents diagnosed with Autism Spectrum Disorder (ASD).

Between the ages of 13 and 17 years.

English-speaking

Sufficient verbal communication skills to participate in interviews, surveys, or tasks.

Disqualifiers

A history of Intelligent Quotient (IQ) < 70.

A history of psychotic, bipolar or seizure disorders as per medical record.

Untreated sleep apnea, a history of narcolepsy, or restless legs syndrome, as per structured interview based on risk screeners.

Trial design

Treatments tested in this trial

  • Transdiagnostic Intervention for Sleep and Circadian Dysfunction

Treatment groups

12 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Milton S. Hershey Medical Center

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator